FdaApplication

ANDA 077432

Back to search

Identifiers

Properties

PropertyValue
applicant_nameFRESENIUS KABI USA LLC
application_typeANDA
approval_date2006-09-29

Products (3)

ProductActive ingredientStrengthDosage form
CARBOPLATINCARBOPLATIN450MG/45ML (10MG/ML)INJECTABLE;INTRAVENOUS
CARBOPLATINCARBOPLATIN150MG/15ML (10MG/ML)INJECTABLE;INTRAVENOUS
CARBOPLATINCARBOPLATIN50MG/5ML (10MG/ML)INJECTABLE;INTRAVENOUS

3 products